AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

PROTEOMICS INTERNATIONAL LAB

0.410

+0.05515.49%

Volume:445.17K

Turnover:172.42K

Market Cap:67.04M

PE:-7.96

High:0.410

Open:0.375

Low:0.365

Close:0.355

Loading ...

Overview Company News Filings

Proteomics Wins US Billing Code for Kidney Function Detection Test

MT Newswires Live

ASX ALERT-AMA grants reimbursement code for Next-Gen PromarkerD test-PIQ.AX

BUZZ-Australia's Proteomics jumps on $4 mln boost for Western Australia facility

BRIEF-Proteomics International Laboratories Says A$6 Million Expansion Of WA Proteomics Facility

Proteomics International Laboratories - a$6 Mln Expansion of Wa Proteomics Facility

THOMSON REUTERS

ASX ALERT-Funding boost for precision diagnostics Proteomics Facility-PIQ.AX

ASX ALERT-First patent for endometriosis blood test - granted in Japan-PIQ.AX

Proteomics International Develops Test for Prediction of Kidney Function Decline in Diabetes Patients, Shares Fall 6%

MT Newswires Live

Next-gen PromarkerD test system released for predicting DKD-PIQ.AX

Proteomics International Laboratories Launches Diagnostic Tool in US

MT Newswires Live

Proteomics International Laboratories Raises AU$12 Million to Fast-Track Diagnostic Test Launch

MT Newswires Live

Proteomics Says Clinical Validation Study Shows Blood Test Can Detect Esophageal Cancer With High Accuracy

MT Newswires Live

Proteomics International Laboratories Secures Patent for OxiDx Technology in China

MT Newswires Live

Proteomics International Laboratories' March Quarter Update Has 'No Surprises,' Says Euroz Hartleys

MT Newswires Live

Proteomics International Laboratories Ltd-Share Purchase Plan Offer Booklet

THOMSON REUTERS

BUZZ-Australia's Proteomics International slides on discounted placement

Proteomics to Raise AU$4.5 Million via Placement; Shares Fall 13%

MT Newswires Live

BRIEF-Proteomics International Laboratories Announces A$4.5 Mln Placement

Proteomics International Laboratories Ltd - Seeks Trading Halt Pending Announcement on Capital Raise

THOMSON REUTERS

Proteomics International Laboratories Forms Advisory Board for Cancer Diagnostic Test; Shares Down 8%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PIQ.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PIQ.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PIQ.AU\",,,,,undefined,":{"symbol":"PIQ.AU","market":"AU","secType":"STK","nameCN":"PROTEOMICS INTERNATIONAL LAB","latestPrice":0.41,"timestamp":1751523120000,"preClose":0.355,"halted":0,"volume":445174,"delay":0,"nameEN":"PROTEOMICS INTERNATIONAL LAB","floatShares":121549097,"shares":163521437,"eps":-0.051492,"marketStatus":"Closed","change":0.055,"latestTime":"07-03 16:12:00 AEST","open":0.375,"high":0.41,"low":0.365,"amount":172416,"amplitude":0.126761,"askPrice":0.41,"askSize":80693,"bidPrice":0.4,"bidSize":85000,"shortable":3,"etf":0,"ttmEps":-0.051492,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1751587200000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.355,"openAndCloseTimeList":[[1751500800000,1751522400000]],"volumeRatio":1.031267,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PIQ.AU\",,,,,undefined,":{"symbol":"PIQ.AU","floatShares":121549097,"roa":"-66.25%","roe":"-136.44%","lyrEps":-0.050665,"volumeRatio":1.031267,"shares":163521437,"dividePrice":0,"high":0.41,"amplitude":0.126761,"preClose":0.355,"low":0.365,"week52Low":0.285,"pbRate":"12.28","psRate":"19.18","week52High":1.12,"institutionHeld":0,"latestPrice":0.41,"committee":0.025994,"eps":-0.051492,"divideRate":0,"volume":445174,"delay":0,"ttmEps":-0.051492,"open":0.375,"prevYearClose":0.8,"prevWeekClose":0.29,"prevMonthClose":0.325,"prevQuarterClose":0.325,"fiveDayClose":0.29,"twentyDayClose":0.395,"sixtyDayClose":0.42},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PIQ.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2548644849","title":"Proteomics Wins US Billing Code for Kidney Function Detection Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2548644849","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548644849?lang=en_us&edition=fundamental","pubTime":"2025-07-03 08:13","pubTimestamp":1751501622,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  received a dedicated billing code from the American Medical Association for its PromarkerD diagnostic test, which identifies kidney function decline in patients with Type 2 diabetes, according to a Thursday filing with the Australian bourse.The new code will take effect for insurance claims from Oct. 1, the filing said.The company also submitted a pricing recommendation for the test to the Centers for Medicare and Medicaid Services , the filing added.Preliminary pricing for the test is expected in September following a review by CMS's advisory panel, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1894683264.USD","LU0661504455.SGD","BK7508","LU1003077747.HKD","PIQ.AU","BK4208","LU0949170772.SGD","BK4588","LU0553294199.USD","CMS","LU0738911758.USD","BK7048","LU1894683348.USD","LU2346227817.USD","LU2637428348.USD","LU0545039389.USD","BK4585","LU2500361329.USD"],"gpt_icon":0},{"id":"2548845875","title":"ASX ALERT-AMA grants reimbursement code for Next-Gen PromarkerD test-PIQ.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2548845875","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548845875?lang=en_us&edition=fundamental","pubTime":"2025-07-03 06:20","pubTimestamp":1751494855,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250702:nASX9H9zc7","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nASX7k8wsV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7048","PIQ.AU"],"gpt_icon":0},{"id":"2548044729","title":"BUZZ-Australia's Proteomics jumps on $4 mln boost for Western Australia facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2548044729","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548044729?lang=en_us&edition=fundamental","pubTime":"2025-07-01 09:07","pubTimestamp":1751332068,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Proteomics jumps on $4 mln boost for Western Australia facility** Proteomics International PIQ.AX jumps as much as 9.2% to A$0.355, highest since June 23** Medical technology firm announces A$6 mln  expansion of its Western Australia facility** Says expansion to support co's implementation of protein biomarker analysis, a technique used to detect specific proteins in biological sample** YTD, PIQ falls ~60%  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nL4N3SY02F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PIQ.AU","BK7508","BK7048"],"gpt_icon":0},{"id":"2548046468","title":"BRIEF-Proteomics International Laboratories Says A$6 Million Expansion Of WA Proteomics Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2548046468","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548046468?lang=en_us&edition=fundamental","pubTime":"2025-07-01 07:29","pubTimestamp":1751326140,"startTime":"0","endTime":"0","summary":"BRIEF-Proteomics International Laboratories Says A$6 Million Expansion Of WA Proteomics FacilityJuly 1 (Reuters) - Proteomics International Laboratories Ltd PIQ.AX:A$6 MILLION EXPANSION OF WA PROTEOMICS FACILITYFurther company coverage: PIQ.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nFWN3SX0WA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7048","PIQ.AU"],"gpt_icon":0},{"id":"2548045540","title":"Proteomics International Laboratories - a$6 Mln Expansion of Wa Proteomics Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2548045540","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548045540?lang=en_us&edition=fundamental","pubTime":"2025-07-01 06:30","pubTimestamp":1751322651,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nFWN3SX0WA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","PIQ.AU","BK7508"],"gpt_icon":0},{"id":"2548457360","title":"ASX ALERT-Funding boost for precision diagnostics Proteomics Facility-PIQ.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2548457360","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548457360?lang=en_us&edition=fundamental","pubTime":"2025-07-01 06:30","pubTimestamp":1751322630,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250630:nASX68mJ49","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nASX1K01LQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","BK7508","PIQ.AU"],"gpt_icon":0},{"id":"2547038100","title":"ASX ALERT-First patent for endometriosis blood test - granted in Japan-PIQ.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2547038100","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547038100?lang=en_us&edition=fundamental","pubTime":"2025-06-30 06:24","pubTimestamp":1751235855,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250629:nASXgccPK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250629:nASX53VnYb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7048","PIQ.AU"],"gpt_icon":0},{"id":"2545693354","title":"Proteomics International Develops Test for Prediction of Kidney Function Decline in Diabetes Patients, Shares Fall 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545693354","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545693354?lang=en_us&edition=fundamental","pubTime":"2025-06-23 12:26","pubTimestamp":1750652774,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  said it developed and released a next-generation PromarkerD test system, an immunoassay-based diagnostic for the prediction of kidney function decline in adults with type 2 diabetes, according to a Monday Australian bourse filing.The test can identify individuals at risk of diabetes-related chronic kidney disease up to four years before clinical symptoms appear, per the filing. It measures two plasma protein biomarkers, ApoA4 and CD5L, alongside age and estimated glomerular filtration rate to generate a personalized risk score.The test identified 86% of at-risk individuals, missed by the current standard-of-care estimated glomerular filtration rate and urinary albumin-to-creatinine ratio tests. In a clinical study with 948 participants, the test showed that the high-risk PromarkerD group demonstrated 44-fold greater odds of kidney decline compared with the low-risk group.The firm's shares fell 6% in recent trading, reaching their lowest point in o","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PIQ.AU","BK7508","BK7048"],"gpt_icon":0},{"id":"2545569994","title":"Next-gen PromarkerD test system released for predicting DKD-PIQ.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2545569994","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545569994?lang=en_us&edition=fundamental","pubTime":"2025-06-23 06:20","pubTimestamp":1750630802,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250622:nASX9lRvZs","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250622:nASXf1r4m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PIQ.AU","BK7048","BK7508"],"gpt_icon":0},{"id":"2544118726","title":"Proteomics International Laboratories Launches Diagnostic Tool in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2544118726","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544118726?lang=en_us&edition=fundamental","pubTime":"2025-06-20 09:46","pubTimestamp":1750383989,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  launched its PromarkerD blood test at the 85th Scientific Sessions of the American Diabetes Association in Illinois, according to a Friday filing with the Australian bourse.The diagnostic tool is designed to predict the onset of diabetic kidney disease up to four years in advance in individuals with type 2 diabetes, the filing said.The test, initially available in California, will be provided by the company's Clinical Laboratory Improvement Amendment-certified reference laboratory, per the filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7048","BK7508","PIQ.AU"],"gpt_icon":0},{"id":"2541882936","title":"Proteomics International Laboratories Raises AU$12 Million to Fast-Track Diagnostic Test Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2541882936","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541882936?lang=en_us&edition=fundamental","pubTime":"2025-06-06 12:56","pubTimestamp":1749185803,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  has completed a AU$12 million capital raise, combining a AU$4.5 million institutional and directors placement with an oversubscribed AU$7.5 million share purchase plan , to accelerate the launch of its suite of diagnostic tests, according to a Thursday filing with the Australian bourse.The upsized and heavily oversubscribed SPP enabled eligible shareholders to purchase approximately 20.3 million new shares at AU$0.37 each, with one free option granted for every two shares, the filing said.Proceeds from the capital raise will fast-track the launch of three Promarker tests in both Australia and the US, support system upgrades in Australia, establish lab platforms in the US, advance pipeline tests, including OxiDx, and cover working capital and offer expenses, the filing added.New shares and new options under the SPP are scheduled to be issued on June 6.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7048","IE00BFXG0V08.USD","XKO.AU","FAST","IE00B5TLWC47.USD","IE00BYQQ9H92.USD","XAO.AU","BK4585","XJO.AU","BK7508","BK4588","BK4567","PIQ.AU","BK4104"],"gpt_icon":0},{"id":"2541017328","title":"Proteomics Says Clinical Validation Study Shows Blood Test Can Detect Esophageal Cancer With High Accuracy","url":"https://stock-news.laohu8.com/highlight/detail?id=2541017328","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541017328?lang=en_us&edition=fundamental","pubTime":"2025-06-05 12:02","pubTimestamp":1749096145,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  said it has published study results showing its PromarkerEso blood test can diagnose Esophageal adenocarcinoma , the predominant form of esophageal cancer, with high accuracy, according to a Thursday filing with the Australian bourse.The test showed accurately detected EAC, with over 91% sensitivity and about 99% specificity in a 147-person validation study, the filing said.Shares of the company rose past 1% in recent Thursday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EAC","BK7508","BK7048","PIQ.AU"],"gpt_icon":0},{"id":"2535444851","title":"Proteomics International Laboratories Secures Patent for OxiDx Technology in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2535444851","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535444851?lang=en_us&edition=fundamental","pubTime":"2025-05-15 12:03","pubTimestamp":1747281809,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories'  subsidiary, OxiDx, received an intellectual property patent in China for its platform technology designed to precisely measure levels of oxidative stress, according to a Thursday filing with the Australian bourse.The patent is valid until 2039. Aside from China, OxiDx's technology has intellectual protection in the US, Japan, Europe, and Australia. The company's application for a second-generation patent is pending in the US, Singapore, and India, the filing stated.The medical technology company's shares were up over 1% in recent Thursday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7048","XKO.AU","XJO.AU","BK7508","PIQ.AU","XAO.AU"],"gpt_icon":0},{"id":"2534253101","title":"Proteomics International Laboratories' March Quarter Update Has 'No Surprises,' Says Euroz Hartleys","url":"https://stock-news.laohu8.com/highlight/detail?id=2534253101","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534253101?lang=en_us&edition=fundamental","pubTime":"2025-05-09 14:52","pubTimestamp":1746773524,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories'  March quarter update contained no major surprises as the company largely reiterated its guided timelines, Euroz Hartleys said in a Thursday note.The research firm noted that the recent placement and share purchase plan should provide the company with adequate cash for 12 months, with about AU$8.6 million in pro forma cash, assuming the plan is successful.The research firm said their investment case is based on the company securing a US licensing partner for its product PromarkerD and for its broader test pipeline, over the medium term.Euroz Hartleys changed Proteomics International Laboratories' rating to speculative buy from hold and cut its price target to AU$0.50 from AU$0.72.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7048","PIQ.AU"],"gpt_icon":0},{"id":"2533321044","title":"Proteomics International Laboratories Ltd-Share Purchase Plan Offer Booklet","url":"https://stock-news.laohu8.com/highlight/detail?id=2533321044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533321044?lang=en_us&edition=fundamental","pubTime":"2025-05-05 08:24","pubTimestamp":1746404651,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUE43VJTX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","PIQ.AU","BK7508"],"gpt_icon":0},{"id":"2529391377","title":"BUZZ-Australia's Proteomics International slides on discounted placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2529391377","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529391377?lang=en_us&edition=fundamental","pubTime":"2025-04-22 11:20","pubTimestamp":1745292018,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Proteomics International slides on discounted placement** Proteomics International Laboratories PIQ.AX slides ~10% to A$0.400, lowest since April 7** Stock set for biggest intraday pct loss since February 28** Medical tech co secures commitments to raise A$4.5 mln  via placement at A$0.37/shr, a ~17% discount to last close** Invites eligible shareholders to participate in a share purchase plan to raise additional A$1 million** Says funds will be used to launch its suite of diagnostic tests** About 137,666 shares traded in stock's busiest session since April 8** PIQ loses 50% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250422:nL4N3R006K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7048","PIQ.AU"],"gpt_icon":0},{"id":"2529839918","title":"Proteomics to Raise AU$4.5 Million via Placement; Shares Fall 13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529839918","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529839918?lang=en_us&edition=fundamental","pubTime":"2025-04-22 11:11","pubTimestamp":1745291479,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  secured firm commitments from new and existing investors to raise about A$4.5 million through the placement of 12.1 million new fully paid ordinary shares at AU$0.37 per share, according to a Tuesday filing with the Australian bourse.The issue price represents a nearly 18% discount to the 15-day volume-weighted average price, the filing said.Participants will also receive one free attaching option for every two shares subscribed with an exercise price of AU$0.50 per share and an expiry date of May 31, 2026, the filing added.A share purchase plan will also be offered to eligible shareholders on the same terms, to raise an additional AU$1 million, with the possibility of oversubscriptions, the company said.The funds raised will support Promarker test launches in Australia and the US, system upgrades for diagnostics, US lab setups, and general working capital, the company added.Shares of the company fell past 13% in recent Tuesday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XKO.AU","PIQ.AU","XAO.AU","BK7508","BK7048","XJO.AU"],"gpt_icon":0},{"id":"2529369523","title":"BRIEF-Proteomics International Laboratories Announces A$4.5 Mln Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2529369523","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529369523?lang=en_us&edition=fundamental","pubTime":"2025-04-22 09:08","pubTimestamp":1745284111,"startTime":"0","endTime":"0","summary":"BRIEF-Proteomics International Laboratories Announces A$4.5 Mln PlacementApril 22 (Reuters) - Proteomics International Laboratories Ltd PIQ.AX:A$4.5 MILLION PLACEMENT AT ISSUE PRICE OF A$0.37 PER SHAREFurther company coverage: PIQ.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250422:nFWN3QZ0WL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PIQ.AU","BK7048","BK7508"],"gpt_icon":0},{"id":"2527405917","title":"Proteomics International Laboratories Ltd - Seeks Trading Halt Pending Announcement on Capital Raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2527405917","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527405917?lang=en_us&edition=fundamental","pubTime":"2025-04-16 08:57","pubTimestamp":1744765044,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nFWN3QT2HQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","PIQ.AU","BK7048"],"gpt_icon":0},{"id":"2525037619","title":"Proteomics International Laboratories Forms Advisory Board for Cancer Diagnostic Test; Shares Down 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525037619","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525037619?lang=en_us&edition=fundamental","pubTime":"2025-04-07 10:46","pubTimestamp":1743994010,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  formed its clinical advisory board for PromarkerEso, a diagnostic blood test for esophageal cancer, according to a Monday filing with the Australian bourse.The advisory board will provide guidance and clinical insights for the global commercialization of PromarkerEso, the filing said.The company is set to launch PromarkerEso in Australia, with other jurisdictions expected to follow, per the filing.Shares fell 8% in recent trade on Monday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7048","PIQ.AU","XKO.AU","XJO.AU","XAO.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":25,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PIQ.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PIQ.AU\",market:\"AU\",,,undefined,":[]}}